£49.00

VDM Verlag Inhibition of Angiogenesis by Potential Chemopreventive Agents: Establishment of a Human In vitro Anti-Angiogenesis Assay and Mechanistic Evaluation of Potent Inhibitors

Price data last checked 100 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£49 today · previous high £49 · all-time low £12

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 631 days • 631 data points (No recent data available)

Historical
Generating forecast...
£49.00 £8.30 £17.18 £26.06 £34.94 £43.82 £52.70 24 May 2024 28 October 2024 04 April 2025 08 September 2025 13 February 2026

Price Distribution

Price distribution over 631 days • 2 price levels

Days at Price
Current Price
83 days 548 days · current 0 137 274 411 548 £12 £49 Days at Price

Price Analysis

Most common price: £49 (548 days, 86.8%)

Price range: £12 - £49

Price levels: 2 different prices over 631 days

Description

A new human in vitro anti-angiogenesis assay was established and applied to identify novel angiopreventive agents. Subsequently, two chemopreventive compounds, xanthohumol (XN) from Humulus lupulus L. (hop) and sulforaphane (SFN), an isothiocyanate derived from cruciferous vegetables (Brassicaceae), were selected for detailed investigation of their angiopreventive potential and mechanisms involved in the inhibition of angiogenesis. Representative targets included effects at the transcriptional levels of pro-angiogenic factors, anti-gelatinolytic and anti-endothelial activity. In vivo, XN was shown to exhibit a strong anti-tumour potency on human breast cancer xenografts mediated by the inhibition of tumour-induced angiogenesis.These findings strongly suggest that XN and SFN represent attractive chemopreventive lead structures possessing a remarkable potential to prevent tumour development.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
02 June 2008
Listed Since
10 June 2008

Barcode

No barcode data available

Similar Products You Might Like

Angiogenesis Inhibition: 180 (Recent Results in Cancer Research, 180)
95% match

Angiogenesis Inhibition: 180 (Recent Results in Cancer Research, 180)

Springer

£84.55 08 Mar 2026
Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy
94% match

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

Springer

£158.00 12 Jan 2026
Angiogenesis in Health, Disease and Malignancy
94% match

Angiogenesis in Health, Disease and Malignancy

Springer

£111.46 12 Jan 2026
Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy
94% match

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

Springer

£203.31 10 Feb 2026
The Biology of Tumors: 9 (Pezcoller Foundation Symposia, 9)
94% match

The Biology of Tumors: 9 (Pezcoller Foundation Symposia, 9)

Springer

£142.28 11 Feb 2026
Modeling Tumor Vasculature: Molecular, Cellular, and Tissue Level Aspects and Implications
94% match

Modeling Tumor Vasculature: Molecular, Cellular, and Tissue Level Aspects and Implications

Springer

£73.88 16 Mar 2026
Pharmacotherapeutic Botanicals for Cancer Chemoprevention
94% match

Pharmacotherapeutic Botanicals for Cancer Chemoprevention

Springer

£99.20 30 Mar 2026
Processing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis (Colloquium Series on Protein Activation and Cancer)
94% match

Processing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis (Colloquium Series on Protein Activation and Cancer)

Morgan & Claypool

£56.86 08 Mar 2026
Nutrition and Cancer Prevention: New Insights into the Role of Phytochemicals: 492 (Advances in Experimental Medicine and Biology)
94% match

Nutrition and Cancer Prevention: New Insights into the Role of Phytochemicals: 492 (Advances in Experimental Medicine and Biology)

Springer

£149.07 24 Feb 2026
Angiogenesis: An Integrative Approach from Science to Medicine
94% match

Angiogenesis: An Integrative Approach from Science to Medicine

Springer

£62.84 22 Jan 2026
Springer Nutrition and Cancer Prevention Phytochemicals Book
94% match

Springer Nutrition and Cancer Prevention Phytochemicals Book

Springer

£163.00 06 Apr 2026
Natural Products in Cancer Prevention and Therapy: 329 (Topics in Current Chemistry, 329)
94% match

Natural Products in Cancer Prevention and Therapy: 329 (Topics in Current Chemistry, 329)

Springer

£95.50 08 Apr 2026
Inflammation, Oxidative Stress, and Cancer: Dietary Approaches for Cancer Prevention
94% match

Inflammation, Oxidative Stress, and Cancer: Dietary Approaches for Cancer Prevention

CRC Press

£80.79 24 Feb 2026
Natural Products for Cancer Chemoprevention: Single Compounds and Combinations
94% match

Natural Products for Cancer Chemoprevention: Single Compounds and Combinations

£108.45 12 Jan 2026
CRC Press - Inflammation, Oxidative Stress, and Cancer Book
94% match

CRC Press - Inflammation, Oxidative Stress, and Cancer Book

CRC Press

£101.08 20 Apr 2026
Springer Natural Products in Cancer Prevention and Therapy 329
94% match

Springer Natural Products in Cancer Prevention and Therapy 329

Springer

£146.87 12 Apr 2026
Anti-Angiogenesis Drug Discovery and Development: Volume 2
94% match

Anti-Angiogenesis Drug Discovery and Development: Volume 2

Elsevier

£61.49 10 Mar 2026
Anticancer Plants: Clinical Trials and Nanotechnology: Volume 3
94% match

Anticancer Plants: Clinical Trials and Nanotechnology: Volume 3

Springer

£112.27 25 Jan 2026
Angiogenesis: Molecular Biology, Clinical Aspects: 263 (NATO Science Series A:, 263)
93% match

Angiogenesis: Molecular Biology, Clinical Aspects: 263 (NATO Science Series A:, 263)

Springer

£140.20 05 Feb 2026
Springer Anticancer Plants: Mechanisms and Molecular Interactions
93% match

Springer Anticancer Plants: Mechanisms and Molecular Interactions

Springer

£113.03 01 Mar 2026
Angiogenesis: Biology and Pathology (Cold Spring Harbor Perspectives in Medicine)
93% match

Angiogenesis: Biology and Pathology (Cold Spring Harbor Perspectives in Medicine)

Cold Spring Harbor Laboratory Press

£85.00 10 Mar 2026
Antiangiogenic Cancer Therapy
93% match

Antiangiogenic Cancer Therapy

CRC Press

£248.98 22 Jan 2026
Phytopharmaceuticals in Cancer Chemoprevention: 2 (CRC Series in Modern Nutrition Science)
93% match

Phytopharmaceuticals in Cancer Chemoprevention: 2 (CRC Series in Modern Nutrition Science)

CRC Press

£220.00 13 Jan 2026
Anti-Angiogenic Functional and Medicinal Foods: 6 (Nutraceutical Science and Technology)
93% match

Anti-Angiogenic Functional and Medicinal Foods: 6 (Nutraceutical Science and Technology)

CRC Press

£87.71 13 Jan 2026